Arbele Revenue and Competitors

Seattle, WA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Arbele's estimated annual revenue is currently $3.4M per year.(i)
  • Arbele's estimated revenue per employee is $200,588

Employee Data

  • Arbele has 17 Employees.(i)
  • Arbele grew their employee count by -6% last year.

Arbele's People

NameTitleEmail/Phone
1
Chairman & FounderReveal Email/Phone
2
Chief Medical OfficerReveal Email/Phone
3
Chief Technology OfficerReveal Email/Phone
4
Director Clinical OperationsReveal Email/Phone
5
Executive Director, Business DevelopmentReveal Email/Phone
6
Research Scientist (IVD)Reveal Email/Phone
7
Postdoctoral ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M50%N/AN/A
#2
$0.9M50%N/AN/A
#3
$5.1M3011%N/AN/A
#4
$5.7M3742%N/AN/A
#5
$1.4M18-10%N/AN/A
#6
$3.7M415%$16MN/A
#7
$1.1M1183%N/AN/A
#8
$0.8M5-81%N/AN/A
#9
$2.5M16-27%N/AN/A
#10
$0.8M8100%N/AN/A
Add Company

What Is Arbele?

Arbele is a locally grown pharmaceutical biotech focused on immunotherapy of cancers, immune disorders and neurological diseases. The company founding team has a strong combination of business development and pharmaceutical R&D, with an accumulation of >30 year experience in multinational drug companies. Our motto is to excel patient healthcare through innovation and breakthrough. Our mission is to deliver innovative and cost-effective therapeutics to treat diseases of unmet needs. We focus on antibody-based therapeutic platforms, including chimeric antigen receptor (CAR)-T and Bi-specific antibody technology, while leveraging new technology on CRISPR genome editing. Our culture ingredients are “integrity and social values”.

keywords:N/A

N/A

Total Funding

17

Number of Employees

$3.4M

Revenue (est)

-6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.2M17-6%N/A
#2
$1.4M1713%N/A
#3
$1.4M1713%N/A
#4
$3.5M1721%N/A
#5
$2.6M18-10%N/A